Speech-Language Pathologists in Cleveland, OH Accepting Medicare

283 Speech-Language Pathologists found. Showing 61 - 80

Advanced Speech & Language Associates Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3722 Berkeley Rd, Cleveland, OH 44118 Phone: 818-397-5716

Mrs. Kylie Marie Volpe, M.A. CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1440 Lakeside Ave E, Room 210, Cleveland, OH 44114 Phone: 216-592-7236

Allison Scarnecchia, M.A., CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2801 Martin Luther King Jr Dr, Cleveland, OH 44104 Phone: 216-448-6474

Ms. Cat R Kenney Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4229 Pearl Rd, Cleveland, OH 44109 Phone: 216-957-2000

Kathleen M Harrison, SLP 3063 Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4553 Hinckley Industrial Pkwy, Cleveland, OH 44109 Phone: 216-299-9643    Fax: 216-635-3530

Lauren E Schiavone Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12000 Harvard Ave, Cleveland, OH 44105 Phone: 216-283-5100

Darci Brasher Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15720 Kipling Ave, Cleveland, OH 44110 Phone: 216-383-1214

Eva Paolucci Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3349 W 125th St, Cleveland, OH 44111 Phone: 216-251-4175

Emily Fitzpatrick, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9500 Euclid Ave # Deskc22, Cleveland, OH 44195 Phone: 216-445-9105

Emma Laurash, MS, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 9500 Euclid Ave # A71, Cleveland, OH 44195 Phone: 216-316-0560

Megan Annmarie Crawford Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14900 Private Dr, Cleveland, OH 44112 Phone: 216-851-8200

Christine Luketic, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3185 W 41st St, Cleveland, OH 44109 Phone: 216-263-7008

Reva Chana Swadron Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1111 Superior Ave E Ste 1800, Cleveland, OH 44114 Phone: 216-838-0000

Stephanie Vondra, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 11635 Euclid Ave, Cleveland, OH 44106 Phone: 216-231-8787    Fax: 216-231-7141

Bridget Petitti, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 11635 Euclid Ave, Cleveland, OH 44106 Phone: 216-231-8787

Masha A Cherpakov, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10701 East Blvd, Cleveland, OH 44106 Phone: 440-724-0855

Mrs. Jean Nisenboum, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11635 Euclid Ave, Cleveland, OH 44106 Phone: 216-325-7526    Fax: 216-325-7626

Emily Hornack, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2500 Metrohealth Dr, Cleveland, OH 44109 Phone: 216-470-5872

Kelly Canterbury Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5004 Glazier Ave, Cleveland, OH 44127 Phone: 216-883-6118

Ms. Amanda Lynn Zbinovec, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1126 Ansel Rd, Cleveland, OH 44108 Phone: 216-838-1850

News Archive

NeuroDerm commences enrollment in ND0801 Phase 2a clinical study of ADD/ADHD in adults

NeuroDerm, Ltd. announced today that patient enrollment has begun in a Phase 2a clinical study of ND0801, a new product for the treatment of Attention Deficit Disorder/Attention Deficit Hyperactivity Disorder (ADD/ADHD) in adults. ND0801, based on a new, proprietary combination with nicotinic actions, is being developed as a dermal patch and will be evaluated for the treatment of cognitive impairment in several disorders including Alzheimer's disease, schizophrenia and advanced Parkinson's disease, among others.

Widening ideological gap in the U.S. may contribute to challenges in medical research

The lightning speed with which scientists developed and tested the COVID-19 vaccine is a true scientific triumph - one that would not have been possible without the more than 70,000 volunteers who participated in clinical trials of the vaccine.

Adiponectin may play a role in development of all-cause dementia and AD in women

A hormone derived from visceral fat called adiponectin may play a role as a risk factor for development of all-cause dementia and Alzheimer disease (AD) in women, according to a study published Online First by the Archives of Neurology, one of the JAMA/Archives journals.

Cerulean commences dosing in CRLX101 Phase 2 study for ovarian cancer

Cerulean Pharma Inc., a leader in developing dynamically tumor-targeted nanopharmaceuticals, today announced that the first patient has been dosed in a Phase 2 study of its lead candidate, CRLX101, in platinum-resistant ovarian cancer patients.

Read more Medical News

› Verified 6 days ago

• 1
• 2
• 3
• 4(current)
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• »